Effectiveness and Safety of Chinese Herbal Medicine for Pediatric Adenoid Hypertrophy: a meta-analysis

Publication date: Available online 19 January 2019

Source: International Journal of Pediatric Otorhinolaryngology

Author(s): Ya-Lei Sun, Hai-Tao Zheng, Jia-Lei Tao, Ming-Chen Jiang, Chan-Chan Hu, Xin-Min Li, Bin Yuan

Abstract

Objective

Chinese herbal medicine has been gradually used to treat pediatric adenoid hypertrophy. This meta-analysis were conducted to evaluate the clinical efficacy and safety of Chinese herbal medicine in the treatment of pediatric adenoid hypertrophy.

Methods

Randomized controlled trials involving Chinese herbal medicine in the treatment of pediatric adenoid hypertrophy were identified from Cochrane Central Register of Controlled Trials, PubMed, EMBASE, Chinese National Knowledge Infrastructure, Chinese Biomedical Database, Wanfang Database and VIP Information Database. The methodological quality of trials was evaluated with Cochrane Handbook criteria, and the Cochrane Collaboration's Review Manager 5.3 software was used for Meta-analysis.

Results

A total of 13 valid articles involving 1038 patients were included.The meta-analysis showed that: Compared with western medicine treatment, Chinese herbal medicine significantly improved clinical efficacy (RR=1.33, 95% CI [1.24,1.43]), and significantly decreased A/N ratio (MD=-0.04,95%CI[-0.05,-0.03]). Chinese herbal medicine also prominently improved the quality of life (MD=-4.77,95%CI[-8.35,-1.20]). Meanwhile, it dramatically improved snoring (MD=-0.46,95%CI[-0.62,-0.30]); mouth breathing (MD=-0.52,95%CI[-0.66,-0.39]); nasal obstruction (MD= -0.56,95%CI[-0.68,-0.45]).

Conclusion

Chinese herbal medicine has good clinical efficacy and safety on pediatric adenoid hypertrophy, which need to be confirmed by high quality, multiple-center, large sample randomized controlled trials.

http://bit.ly/2FBVC7N